Mark Penney is currently the Director of Translational PKPD at AstraZeneca, a position held since 2022. Previously, they worked as a Senior Pharmacometrician at AstraZeneca R&D from 2006 to 2011, and held the role of PKPD Modelling Specialist at MedImmune from 2011 to 2015. Mark also served as Associate Director of Mechanistic PKPD at UCB from 2015 to 2022, and was an Expert Modeller at Novartis from 2003 to 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices